Obsidian Therapeutics, Inc. (OBX)
11.24
+1.64
(+17.08%)
USD |
NASDAQ |
Nov 06, 10:17
Obsidian Therapeutics Net Income (Quarterly) : -25.86M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.86M |
| March 31, 2026 | -1.606M |
| December 31, 2025 | 153.10M |
| September 30, 2025 | -1.388M |
| June 30, 2025 | -26.90M |
| March 31, 2025 | -1.592M |
| December 31, 2024 | -4.931M |
| September 30, 2024 | -5.581M |
| June 30, 2024 | -4.064M |
| March 31, 2024 | -4.381M |
| December 31, 2023 | -5.587M |
| September 30, 2023 | -15.07M |
| June 30, 2023 | -20.71M |
| March 31, 2023 | -17.71M |
| December 31, 2022 | -16.19M |
| Date | Value |
|---|---|
| September 30, 2022 | -16.03M |
| June 30, 2022 | -14.56M |
| March 31, 2022 | -15.44M |
| December 31, 2021 | -16.81M |
| September 30, 2021 | -22.63M |
| June 30, 2021 | -22.39M |
| March 31, 2021 | -18.72M |
| December 31, 2020 | -20.06M |
| September 30, 2020 | -17.08M |
| June 30, 2020 | -18.66M |
| March 31, 2020 | -18.42M |
| December 31, 2019 | -16.67M |
| September 30, 2019 | -13.35M |
| June 30, 2019 | -11.56M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | 39.39M |
| Cue Biopharma, Inc. | -153.07M |
| Yarrow Bioscience, Inc. | -2.899M |
| Faeth Therapeutics, Inc. | -20.40M |
| Immuneering Corp. | -24.19M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.86M |
| EPS Diluted (Quarterly) | -237.20 |
| Enterprise Value | 299.55M |
| Earnings Yield | 1.44K% |
| Normalized Earnings Yield | -1106.83 |